About Hummingbird Diagnostics
Hummingbird Diagnostics is a Healthcare company based in Heidelberg (Germany) founded in 2015 by Jochen Kohlhaas and Karoly Nikolich. Blood tests integrating disease and immune response biomarkers are developed. The company has 20 employees. Its chief executive, as recorded, is Jochen Kohlhaas. Hummingbird Diagnostics offers products and services including Molecular Blood Tests and Lung Cancer Screening. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics. Its legal entity is Hummingbird Diagnostics GmbH.
Company details
Founded in 2015 and based in Heidelberg, Germany, Hummingbird Diagnostics operates in the diagnostics sector of personalized medicine. Molecular blood tests are developed for early disease detection, treatment monitoring, and prediction of therapeutic responses. Small RNA biomarkers from whole blood samples are utilized in these analyses to advance integrated biomarker approaches. Operations focus on immune response integration to support clinical applications.
- Headquarters Heidelberg, Germany
- Employees 20
- Founders Jochen Kohlhaas, Karoly Nikolich
- SectorsHealthcare
- Phone•••• ••••
- Website hummingbird-diagnostics.com
- Social LinkedIn
- Legal Name Hummingbird Diagnostics Gmbh
- Investors
- Employee Count20
Products & Services of Hummingbird Diagnostics
Hummingbird Diagnostics offers a comprehensive portfolio of products and services, including Molecular Blood Tests and Lung Cancer Screening.
Tests for analyzing tumor and immune biomarkers in blood for disease detection.
Service for early lung cancer detection using molecular biomarkers.
Funding Insights of Hummingbird Diagnostics
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Hummingbird Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2016 | Seed | – | – |
1 investors in total: 1 institutional.
Investors in Hummingbird Diagnostics
Hummingbird Diagnostics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include GreyBird Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are focused on precision diagnostic technologies. | greybirdventures.com |
Investor details for Hummingbird Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Hummingbird Diagnostics
2 people are tracked at Hummingbird Diagnostics (2 in leadership); the tracked headcount is 20.
| Name | Role | Group |
|---|---|---|
Jochen Kohlhaas | Co-Founder & CEO | Leadership |
Karoly Nikolich | Co-Founder | Leadership |
Complete people profiles for Hummingbird Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Hummingbird Diagnostics
2 dated milestones of Hummingbird Diagnostics across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Hummingbird Diagnostics is founded.
- Funding First funding round.
Web traffic of Hummingbird Diagnostics
Websites that share an audience with Hummingbird Diagnostics (hummingbird-diagnostics.com).
Websites whose visitors overlap most with Hummingbird Diagnostics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| gerbu.de | 100% | #4,209,132 | View details | ||
brain-biotech-group.com | brain-biotech-group.com | 99% | – | ||
| molecularhealth.com | 99% | View details | |||
aca-cell.com | aca-cell.com | 99% | – | ||
| veraxa.com | 99% | 4.2K | #4,458,181 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for Hummingbird Diagnostics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Hummingbird Diagnostics
Hummingbird Diagnostics was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Hummingbird Diagnostics is headquartered in Heidelberg, Germany. It is registered at Heidelberg, Baden-wurttemberg, Germany.
Jochen Kohlhaas is the CEO of Hummingbird Diagnostics, as recorded in our data. They have also founded this company.
Hummingbird Diagnostics has 20 employees.
Founded in 2015 and based in Heidelberg, Germany, Hummingbird Diagnostics operates in the diagnostics sector of personalized medicine. Molecular blood tests are developed for early disease detection, treatment monitoring, and prediction of therapeutic responses. Small RNA biomarkers from whole blood samples are utilized in these analyses to advance integrated biomarker approaches. Operations focus on immune response integration to support clinical applications.
Hummingbird Diagnostics offers Molecular Blood Tests and Lung Cancer Screening.
Hummingbird Diagnostics has 1 investor. Key investors include GreyBird Ventures.
Hummingbird Diagnostics operates through Hummingbird Diagnostics Gmbh.